To answer big, bold questions in cancer research, researchers need a high-performance infrastructure designed to handle the friction of innovation. At the Koch Institute, we provide institutional support, specialized facilities, and clinical networks required to prevent breakthroughs from stalling before they gain traction. By smoothing the path for our researchers, we ensure that important discoveries have the momentum to reach the patients who need them most.
The Swanson Biotechnology Center (SBC) Core Facilities, a suite of over a dozen research support facilities, lower the barriers to high-stakes experimentation. By providing first-rate expertise and technological resources—from advanced proteomics to high-speed imaging—the SBC Core Facilities allows researchers to work with a level of precision and efficiency that would be next to impossible to achieve in a solitary lab.
Research centers provide sustained support for discovery science and technological innovations in strategic areas, and serve as hubs for interdisciplinary collaboration at the Koch Institute and beyond. Through the Frontier Research Program, we provide the seed funding for ground-breaking ideas that are too early for traditional grants, while the Bridge Project creates a direct link to clinical oncology, pairing MIT scientists with doctors from Harvard’s hospital consortium. Our ongoing collaborations with academia, industry, and clinical centers, such as through the BioConvergence Cancer Alliance, keep our research grounded in the issues that impact patients most.
By championing research projects from beginning to end, KI ensures that big, bold questions aren't just asked, they are answered.
